Abstract
Interstitial lung diseases comprise a large group of pulmonary disorders characterized by lung inflammation and fibrosis. Often, these disorders are progressive leading to irreversible tissue scaring. The absence of effective and safe anti-fibrotic drugs has prompted the search for targets for intervention that could lead to new strategies for treatment. Animal models of lung fibrosis, although not resembling exactly the human condition, represent invaluable tools for the exploration of the factors and mechanisms involved in the development of lung fibrosis. In this review, we briefly discuss current concepts related to the pathogenesis of lung fibrosis followed by a more thorough discussion of currently available animal models of lung fibrosis. Experimental models induced by chemical agents, haptens, infection, genetic manipulation, and irradiation are discussed as are cell-mediated models and spontaneous models of lung fibrosis in domestic animals.
Keywords: Animal model, epithelial-mesenchymal transition, idiopathic pulmonary fibrosis, inflammation, interstitial lung disease, myofibroblast, epithelial cell.
Current Respiratory Medicine Reviews
Title:Animal Models of Lung Fibrosis
Volume: 11 Issue: 2
Author(s): Gianluca Bagnato and Jesse Roman
Affiliation:
Keywords: Animal model, epithelial-mesenchymal transition, idiopathic pulmonary fibrosis, inflammation, interstitial lung disease, myofibroblast, epithelial cell.
Abstract: Interstitial lung diseases comprise a large group of pulmonary disorders characterized by lung inflammation and fibrosis. Often, these disorders are progressive leading to irreversible tissue scaring. The absence of effective and safe anti-fibrotic drugs has prompted the search for targets for intervention that could lead to new strategies for treatment. Animal models of lung fibrosis, although not resembling exactly the human condition, represent invaluable tools for the exploration of the factors and mechanisms involved in the development of lung fibrosis. In this review, we briefly discuss current concepts related to the pathogenesis of lung fibrosis followed by a more thorough discussion of currently available animal models of lung fibrosis. Experimental models induced by chemical agents, haptens, infection, genetic manipulation, and irradiation are discussed as are cell-mediated models and spontaneous models of lung fibrosis in domestic animals.
Export Options
About this article
Cite this article as:
Bagnato Gianluca and Roman Jesse, Animal Models of Lung Fibrosis, Current Respiratory Medicine Reviews 2015; 11 (2) . https://dx.doi.org/10.2174/1573398X11666150619183100
DOI https://dx.doi.org/10.2174/1573398X11666150619183100 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Protective Role of Diabetes Mellitus on Abdominal Aortic Aneurysm Pathogenesis: Myth or Reality?
Current Vascular Pharmacology New Treatment Options Using 5-HT3 Receptor Antagonists in Rheumatic Diseases
Current Topics in Medicinal Chemistry HCV-Related Central and Peripheral Nervous System Demyelinating Disorders
Inflammation & Allergy - Drug Targets (Discontinued) Cardiac Involvement in ANCA (+) and ANCA (-) Churg-Strauss Syndrome Evaluated by Cardiovascular Magnetic Resonance
Inflammation & Allergy - Drug Targets (Discontinued) Recent Advance in Aminopeptidase N (APN/CD13) Inhibitor Research
Current Medicinal Chemistry Cardiovascular Disease in Juvenile Idiopathic Arthritis
Current Vascular Pharmacology Disease Modifying Approaches for Alzheimers Pathology
Current Pharmaceutical Design Role of Inflammation in Diabetic Nephropathy
Current Diabetes Reviews Thalidomide Metabolism and Hydrolysis: Mechanisms and Implications
Current Drug Metabolism Skin Tests in the Diagnosis of Drug Hypersensitivity Reactions
Current Pharmaceutical Design Anti-Endothelial Cell Antibodies in Patients with Cerebral Small Vessel Disease
Current Neurovascular Research Impaired Clearance of Neutrophils Extracellular Trap (NET) May Induce Detrimental Tissular Effect
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Recent Progress of Machine Learning in Gene Therapy
Current Gene Therapy Studies on Novel Pyridine and 2-pyridone Derivatives of N-arylpiperazine as α-adrenoceptor Ligands
Medicinal Chemistry Melatonin Role in Experimental Arthritis
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Mechanisms Explaining the Influence of Subclinical Hypothyroidism on the Onset and Progression of Chronic Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets The Interplay between Cofilin and Phospho-Cofilin: Its Role in Maintaining Blood Brain Barrier Integrity
CNS & Neurological Disorders - Drug Targets Juvenile Systemic Lupus Erythematosus
Current Pediatric Reviews Action and Disposition of the β3-Agonist Nebivolol in the Presence of Inflammation; An Alternative to Conventional β1-Blockers
Current Pharmaceutical Design FDG-PET/CT in Rheumatoid Arthritis: A Review
Current Molecular Imaging (Discontinued)